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Abstract
Background: We investigated the mechanism of action of silymarin in a mouse model of renal ischemia–reperfusion
injury (I/R) to ascertain its role in the treatment of I/R injury.
Methods: Twenty-four C57BL/6 male mice were divided randomly into three groups: control (sham);
ischemia–reperfusion (I/R); silymarin + ischemia–reperfusion (silymarin + I/R). In sham mice, an abdominal
incision was made, followed by dissection of the bilateral renal pedicle, with no further cross-clamping of
arteries. Silymarin + I/R mice were administered 100 mg/kg silymarin daily for 7 consecutive days before surgery,
whereas I/R mice were administered (i.g.) 0.9 % saline + 0.1 % (v/v) ethanol daily for 7 consecutive days before surgery.
Silymarin + I/R and I/R mice were subjected to renal ischemia to induce acute kidney injury after 45-min clamping of
bilateral renal arteries. Serum levels of creatinine and blood urea nitrogen levels were measured. Periodic acid–Schiff
(PAS) staining was undertaken to detect damaged renal tissue. Myeloperoxidase (MPO) activity and immunofluorescent
detection of CD68 expression was undertaken for each group. Levels of inflammatory cytokines secreted by renal tissue
were monitored by ELISA. Apoptosis was detected by TUNEL staining. Expression of cleaved-caspase-3, Bcl-2 and Bax
was detected by western blotting.
Results: Serum creatinine and blood urea nitrogen levels were elevated in silymarin + I/R and I/R groups
compared with sham mice (p < 0.05), whereas those in the I/R group were significantly higher than in the
silymarin + I/R group (p < 0.05). Number of damaged renal tubule cells and apoptotic cells in sham and
silymarin + I/R groups was significantly lower than in I/R mice. MPO activity and secretion of inflammatory
cytokines in silymarin + I/R and I/R groups was reduced (p < 0.05), and CD68 expression in silymarin + I/R
mice was lower than in I/R mice (p < 0.05). Expression of cleaved-caspase-3 and Bax in the I/R group was
significantly higher than in sham mice, whereas Bcl-2 expression was lower than in silymarin + I/R mice (p < 0.05).
Conclusions: Silymarin can inhibit renal I/R injury by inhibiting release of inflammatory factors and regulating apoptosis.
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Background
Ischemia–reperfusion (I/R) is a common cause of acute
kidney injury after kidney transplantation, embolism in
renal arteries or cross-clamping surgery. The main cause
of reperfusion injury is the large influx of calcium, oxy-
gen free radicals and inflammatory cytokines, which
cause extensive damage to tissue [1].
Silymarin is a polyphenolic flavonoid extracted from
plants. It is used commonly for the treatment of drug-
induced liver disease [4]. Several studies have shown that
silymarin has antioxidant properties, and inhibits inflam-
mation and apoptosis [2]. Given that kidney injury due
to I/R involves oxidation, inflammation and apoptosis,
we hypothesized that silymarin may have a protective
role in this type of injury. Hence, we investigated the




Twenty-four healthy male C57BL/6 mice (6–8 weeks;
25–28 g) were purchased from the Shanghai Experimen-
tal Animal Center of Chinese Academy of Sciences
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(Shanghai, China). Silymarin was obtained from Sigma–
Aldrich (St. Louis, MO, USA). Antibodies against
caspase-3, cleaved-caspase-3, Bcl-2, Bax and glyceralde-
hyde 3-phosphate dehydrogenase were purchased from
Cell Signaling Technology (Danvers, MA, USA). Anti-
rabbit secondary antibody was obtained from Wuhan
Boster (Wuhan, China). A Myeloperoxidase (MPO)
Assay kit was purchased from Nanjing Jiancheng Bio-
engineering Institute (Nanjing, China). An enzyme-
linked immunosorbent assay (ELISA) kit was obtained
from eBioscience (San Diego, CA, USA).
Animal model
Twenty-four C57BL/6 male mice were divided randomly
into three groups: control (sham); ischemia–reperfusion (I/
R); silymarin + ischemia–reperfusion (silymarin + I/R). The
sham group underwent abdominal incision and dissection of
the bilateral renal pedicle only. No further cross-clamping of
arteries was undertaken on this group. Silymarin + I/R mice
were administered silymarin (100 mg/kg body weight) daily
for 7 consecutive days before surgery. I/R mice were admin-
istered (i.g.) physiologic (0.9 %) saline + 0.1 % (v/v) ethanol
daily for 7 consecutive days before surgery. Application of ex-
perimental animals get approval of Ethics Committee.
Preoperative preparations
After a 12-h fast, anesthesia was induced by injection of
2 % (w/v) sodium thiopental (50 mg/kg, i.p.). An incision
was made into the abdominal cavity. The intestine was
moved to expose the bilateral renal pedicle without dam-
aging the renal artery. The renal artery and renal vein
were occluded using a clip for 45 min, followed by reper-
fusion for 24 h, after which point mice were sacrificed.
Blood was collected from the inferior vena cava. The left
kidney was removed and fixed in 4 % (w/v) paraformalde-
hyde. The right kidney was placed in liquid nitrogen.
Kidney function tests
All blood samples were left at room temperature for
30 min and centrifuged at 5000 rpm for 10 min at room
temperature. Supernatants were collected, and serum
concentrations of creatinine and blood urea nitrogen
(BUN) measured at the People’s Hospital Affiliated with
Jiangsu University.
Pathology of kidney tissue
Serial sections (thickness, 4 μm) were washed with
distilled water, incubated in 0.5–1 % (v/v) aqueous peri-
odate for 5–10 min, and washed three times with
distilled water. Sections were differentiated, followed by
incubation in Schiff ’s reagent for 10–30 min. After stain-
ing, sections were subjected to washing three times with
sulfite, then with distilled water. Sections were counter-
stained with hematoxylin to identify nuclei. Grading of
renal tubular necrosis was based on a points system for
staining: 0 points, no damage; 1, ≤10 % tissue staining; 2,
11–25 %; 3, 26–45 %; 4, 46–75 %; 5, ≥76 %. Each sample
was selected randomly. For each specimen, the mean
lesion score was taken from five fields of view.
MPO activity in kidney tissue
MPO activity in kidney tissue was measured according
to manufacturer instructions. Tissue from each group
was washed in 0.9 % saline and weighed to ensure equal
amounts were used. Tissue was homogenized on ice in
saline (1:9) and centrifuged at 12,000 rpm for 1 min at
room temperature. Supernatants were added to extracts
adjoining an anisidine-H2 reaction system, mixed and
incubated for 20 min at 60 °C in a water bath. The
absorbance of each tube was measured at 460 nm.
After deparaffinization and antigen retrieval, paraffin-
embedded kidney sections (thickness, 2 μm) were incu-
bated with 10 % (v/v) fetal bovine serum for 30 min,
Fig. 1 Effect of silymarin on renal tissue after renal I/R injury. Serum levels of creatinine and blood urea nitrogen (BUN) levels in the I/R group
were 22.7 ± 1.2 and 1295.7 ± 64.2 mg/L, respectively, which were significantly higher than in sham mice (creatinine: 4.4 ± 0.2 mg/L; urea nitrogen:
291.7 ± 17.7 mg/L; p < 0.05). However, serum levels of creatinine and BUN levels in silymarin + I/R mice were significantly lower than those in I/R
mice (creatinine: 14.0 ± 3.9 mg/L; BUN: 571.7 ± 17.0 mg/L; p < 0.05) A meamure creatinine result. B meamure urea nitrogen result
Tan et al. Diagnostic Pathology  (2015) 10:198 Page 2 of 6
followed by incubation with rat anti-CD68 primary
antibody in a moist chamber overnight at 4 °C. After
washing, secondary antibodies (fluorescein isothiocyanate-
conjugated rabbit anti-mouse IgG and FITC-conjugated
goat anti-rat IgG) were used.
Detection of inflammatory cytokines by ELISA
Levels of interleukin (IL)-1β, IL-6 and tumor necrosis
factor (TNF)-α in kidney homogenates from each group
were detected according to manufacturer instructions.
Terminal deoxynucleotidyl transferase dUTP nick-end
labeling (TUNEL)
To identify apoptotic cells in vivo, staining of paraffin-
embedded sections (thickness, 6 μm) was evaluated
using a TUNEL kit according to manufacturer instruc-
tions. Apoptotic cells were visualized by fluorescence
microscopy and appeared yellow-green.
Western blotting
Standard procedures for western blotting were used to
monitor expression of cleaved-caspase-3, Bcl-2 and Bax.
Briefly, renal tissue homogenates (50 μm) were subjected
to electrophoresis on a 15 % (w/v) sodium dodecyl
sulfate-polyacrylamide gel. Protein was transferred to
nitrocellulose membranes, blocked with 5 % (w/v)
skimmed milk overnight, and incubated with appropriate
primary antibodies. Proteins were visualized and quanti-
fied using an enhanced chemiluminescence system.
Fig. 3 Effect of silymarin on MPO activity. MPO activity in the I/R
group (52.0 ± 6.3 U/g) was significantly higher than that in sham
mice (7.6 ± 1.2 U/g), whereas MPO activity in silymarin + I/R mice
(31.8 ± 5.4 U/g) was significantly lower than in the I/R group. *p < 0.05.
MPO activity in renal tissue of mouse in each group (U/g)
Fig. 2 Effect of silymarin on renal tissue damage and cellular architecture after renal I/R injury. Renal histologic changes in the outer medulla
from mice of sham, silymarin, I/R and silymarin + I/R groups were assessed using periodic acid–Schiff (PAS) staining. Representative slides from
each group (original magnification ×400) are shown. a Histologic damage in the outer medulla was scored by counting the percentage of tubules that
displayed tubular necrosis, cast formation and tubular dilation as follows: 0, normal; 1, <10 %; 2, 10–25 %; 3, 26–50 %; 4, 51–75 %; 5, >75 %. Ten
random fields of view per kidney section (×200 magnification) were used for counting. b Number of necrotic tubules was measured in 10 random
fields per kidney section. Data are the mean ± SE (n = 6/group); *p < 0.05 vs. I/R.c Periodic acid–Schiff (PAS) staining image from each group
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Statistical analyses
IBM SPSS Statistics, Version 19.0 (IBM, Armonk, NY,
USA) was used data analyses. Data are the mean ± stand-
ard deviation. Two-way ANOVA was used to compare
between multiple groups.
Results
Silymarin reduces serum levels of creatinine and BUN
levels
Serum levels of creatinine and BUN levels in the I/R
group were 22.7 ± 1.2 and 1295.7 ± 64.2 mg/L, respect-
ively, which were significantly higher than those in sham
mice (creatinine: 4.4 ± 0.2 mg/L; BUN: 291.7 ± 17.7 mg/L,
p < 0.05). However, serum levels of creatinine and BUN
levels in silymarin + I/R mice were significantly lower
than those in I/R mice (creatinine: 14.0 ± 3.9 mg/L;
BUN: 571.7 ± 17.0 mg/L, p < 0.05; Fig. 1).
Periodic acid–Schiff (PAS) staining revealed that sham
mice had normal renal tubular epithelial cells that did
not change significantly. In the I/R group, the renal
medullary junction showed extensive necrosis in tubular
epithelial cells, cell loss and infiltration of inflammatory
cells. Mice in the silymarin + I/R group showed only
mild edema of tubular epithelial cells, as well as only
mild necrosis and damage to renal tubules, which
was reduced significantly compared with that in the
I/R group (p < 0.05; Fig. 2). The tubular necrosis
score of silymarin + I/R mice was 1.75 ± 0.16 min,
which was significantly lower than that of I/R mice
(4.17 ± 0.29 min; p < 0.05).
Silymarin inhibits the inflammatory response
MPO activity in I/R mice was 52.0 ± 6.3 U/g, which
was significantly higher than that in sham mice (7.6 ±
1.2 U/g; p < 0.05) and silymarin + I/R mice (31.8 ± 5.4
U/g, p < 0.05; Fig. 3).
I/R mice had a significantly greater number of CD68-
positive cells in renal tissue (12.1 ± 0.7) compared with
that in silymarin + I/R mice (6.6 ± 0.8, p < 0.05; Fig. 4).
Levels of TNF-α, IL-1β and IL-6 in the I/R group were
increased significantly compared with those in sham and
silymarin + I/R mice (p < 0.05; Table 1).
Silymarin inhibits apoptosis
Few apoptotic cells were detected in sham mice (0.66
± 0.3), but a significant increase was observed in I/R
kidney tissue (47.67 ± 2.4, p < 0.05). The number of
apoptotic cells in silymarin + I/R mice was signifi-
cantly lower when compared with that in I/R mice
(27.67 ± 3.56, p < 0.05; Fig. 5).
Expression of Bax and cleaved-caspase-3 in sham mice
was 0.80 ± 0.15 and 0.95 ± 0.13, respectively, which was
significantly upregulated in I/R mice (Bax: 0.57 ± 0.09;
cleaved-caspase-3: 0.38 ± 0.10; p < 0.05). No difference was
observed for Bcl-2 expression. Expression of Bax and
cleaved-caspase-3 in silymarin + I/R mice was significantly
lower than that in I/R mice (Bax: 0.64 ± 0.11; cleaved-
caspase-3: 0.37 ± 0.13, p < 0.05), whereas Bcl-2 expression
was upregulated significantly compared with that in the I/
R group (1.73 ± 0.32 vs. 0.13 ± 0.08, p < 0.05; Fig. 6).
Discussion
Renal I/R injury is a common cause of acute kidney
injury, and can lead to irreversible kidney damage,
increased patient suffering and high mortality. There-
fore, interventions before such injury is sustained will be
beneficial. Animal models of renal I/R injury suggest
that ischemic and hypoxic tissue damage is caused
during restoration of renal blood flow. This damage
results in the release of large amounts of mitochondrial
reactive oxygen species, calcium overload and release of
Table 1 Levels of TNF-α, IL-1β and IL-6
Group TNF-α (pg/mg) IL-1β (pg/mg) IL-6 (pg/mg)
sham 212.5 ± 5.21c 271.1 ± 51.37c 143.0 ± 31.1c
I/R 2114.3 ± 110.53a 2721.9 ± 171.22a 1949.0 ± 70.5a
I/R + silymarin 1245.7 ± 135.31b 1514.4 ± 36.32b 1009.1 ± 110.6b
Levels of TNF-α, IL-1β and IL-6 were increased significantly in the I/R group
compared with sham and silymarin + I/R groups
.c significantly reduced compared with a and b,respectively. (p < 0.05)
Fig. 4 CD68 expression in renal tissue. Number of CD68-positive cells in renal tissue from the I/R group (12.1 ± 0.7) was significantly reduced compared
with that in silymarin + I/R mice (6.6 ± 0.8). *p < 0.05
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inflammatory cytokines that cause apoptosis and necro-
sis and, subsequently, kidney damage [3]. Thus, drugs
that suppress inflammation, necrosis and apoptosis may
have therapeutic potential.
Silymarin has antioxidant properties and is used
commonly to treat drug-induced liver disease [4]. Sily-
marin has been shown to inhibit the NFκB signaling
pathway and reduce expression of the inflammatory
cytokines TNF-α, IL-1β and IL-6, resulting in inhib-
ition of the inflammatory response [5]. Li et al. showed
the protective effects of silymarin against I/R injury in
the heart, liver and brain [5]. In elegant experiments
using mice, Turgut et al. demonstrated that silymarin
pretreatment significantly inhibited renal I/R injury,
reduced malondialdehyde levels, increased expression
of superoxide dismutase, and acted as an antioxidant
[6]. Similarly, we have shown in mice that silymarin
pretreatment can reduce necrosis of renal tubular
epithelial cells, serum levels of creatinine and BUN
levels, and thereby improve kidney function. Sily-
marin pretreatment can also significantly reduce
expression of inflammatory cytokines (TNF-α, IL-1β, IL-
6), suggesting that silymarin can inhibit the immune
response in renal I/R and have renoprotective effects.
Apoptosis is considered one of the major mechanisms
of renal I/R injury, and is triggered by certain factors in
vivo. Therefore, inhibition of apoptosis could reduce renal
I/R injury significantly. Studies have confirmed that in-
creases in levels of TNF-α, IL-lβ and IL-6 can damage tis-
sue by inducing apoptosis [7]. Studies have also shown
that apoptosis of renal cells and the regulation of expres-
sion of Bax and Bcl-2 are closely related [8]. Bcl-2 can
inhibit the generation of free radicals, overload of intracel-
lular calcium, permeability of mitochondrial membranes,
release of cytochrome c and activation of caspase-3. Bax
promotes activation of cleaved-caspase-3 and apoptosis.
Therefore, the ratio of Bax to Bcl-2 determines whether a
cell survives or undergoes apoptosis. A recent study
showed that specific knockout of p53 in renal tubular
epithelial cells significantly reduces apoptotic cell death as
well as subsequent renal injury and renal fibrosis [9, 10,
11]. Here, we have shown that silymarin pretreatment can
significantly increase expression of Bcl-2 protein and
reduce Bax expression in kidney tissue. Moreover, sily-
marin can inhibit cleavage of caspase-3 and thereby
reduce apoptosis of renal tubular epithelial cells.
Conclusions
Our results suggest that silymarin may have a protective
role against renal I/R injury by inhibiting the inflammatory
response and apoptosis. Therefore, silymarin treatment
during renal I/R injury may have promising clinical applica-
tions. Nevertheless, the precise mechanism of action of
silymarin requires further investigation.
Fig. 6 Protein expression. Expression of Bax and cleaved-caspase-3
in sham mice was significantly reduced compared with that in the I/
R group (p < 0.05). A similar result was seen for silymarin + I/R mice.
However, Bcl-2 expression was increased significantly (p < 0.05) in
silymarin + I/R mice
Fig. 5 Detection of apoptosis. Few apoptotic cells were observed in sham mice. The I/R group mice had widespread apoptosis
compared with sham mice (47.67 ± 2.40, p < 0.05). Silymarin + I/R mice had significantly fewer apoptotic cells (27.67 ± 3.56) compared
with the I/R group
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